(Vienna, 26 September 2018) Cancer patients are known to have an increased risk of thrombosis. As part of the CATS study, MedUni Vienna researchers have now investiga...

Up to half of people with Alzheimer’s disease (AD) use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conduct...

Berlin, Germany, 2 October 2018 ­- When treated with once-daily Ryzodeg®, people with type 2 diabetes achieved similar blood sugar control with half the number of dai...

Berlin, Germany, 2 October 2018 ­- According to results of a post-hoc analysis people with both type 1 and type 2 diabetes in clinical practice may achieve improved g...

26 September 2018 – A leading provider of assay solutions to pharma, biotech, and clinical research organisations has streamlined its approach to quality assurance an...

Bottom Line: Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) were significantly more likely to relapse than pediatric ALL patients, ...

Thrombolytic Science, LLC (TSI) today announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of...

Mataró, Barcelona, Spain, September 26, 2018- Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces the co...